3-(3,4-difluorophenyl)-4-(4-(methylsulfonyl)phenyl)-2(5h)-furanone has been researched along with Brain Ischemia in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chen, W; Correa, L; Cramer, M; Lorrain, D; Munoz, B; Payne, J; Prasit, P; Reger, TS; Smith, ND; Stock, N; Yang, J; Zunic, J | 1 |
1 other study(ies) available for 3-(3,4-difluorophenyl)-4-(4-(methylsulfonyl)phenyl)-2(5h)-furanone and Brain Ischemia
Article | Year |
---|---|
Water soluble prodrug of a COX-2 selective inhibitor suitable for intravenous administration in models of cerebral ischemia.
Topics: Animals; Blood; Brain; Brain Ischemia; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Disease Models, Animal; Infusions, Intravenous; Inhibitory Concentration 50; Prodrugs; Prostaglandin-Endoperoxide Synthases; Rats; Solubility; Tissue Distribution | 2005 |